Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

MD Logic Health announces major partnership with AvalonX

MD Logic Health ("MD Logic"), a leading provider of professional-grade nutraceuticals and physician-recommended dietary supplements made in the USA, today announced a major partnership with AvalonX, founded by Melanie Avalon.


News provided by

MD Logic Health

Nov 16, 2021, 08:00 ET

Share this article

Share toX

Share this article

Share toX

Serrapeptase 125
Serrapeptase 125

MIAMI, Nov. 16, 2021 /PRNewswire-PRWeb/ -- This partnership was forged through a mutual dedication to create supplements from the purest, ethically, and sustainably sourced raw materials to create potent and effective nutraceuticals.

AvalonX Founder and President Melanie Avalon said, "I am so proud to announce my partnership with MD Logic Health. I have been seeking to create a supplement line that could meet my uncompromising standards. After an exhaustive search, MD Logic fit all my criteria. They welcomed my challenge to meet the AvalonX standards, and make the cleanest, purest serrapeptase supplement possible. MD Logic even created a dedicated small batch process to ensure we could make our Serrapeptase 125 supplement without potentially toxic fillers, such as stearates and palmitates. Despite the costs, we also agreed to use amber glass bottles, to help protect the products and environment from plastics and chemical byproducts, such as phthalates. I have never felt so comfortable with a supplement partner as I do with MD Logic. Together we will support my current and future audience through the AvalonX mission for purity, potency, transparency, and trust."

I am so proud to announce my partnership with MD Logic Health. They welcomed my challenge to meet the AvalonX standards, and make the cleanest, purest serrapeptase supplement possible. I have never felt so comfortable with a supplement partner as I do with MD Logic.

Post this

MD Logic COO and Cofounder Scott Emmens added, "Our partnership with Melanie is such an organic fit. From the onset of our initial discussion, it was clear our health missions were closely aligned. Melanie is well known in the biohacking sphere for her expertise, passion, and commitment to her audience. Combined with MD Logic's industry mastery in sourcing, formulation, logistics, and manufacturing process, we have a true synergy. We create every MD Logic product with pride for the health of our community, our friends, and our families. We look forward to serving the many members of the AvalonX community with that same pride."

The first product for the partnership will be Serrapeptase 125 by AvalonX Powered by MD Logic. Serrapeptase is a potent proteolytic enzyme originally created by the Japanese silkworm. Taken in the fasted state, it breaks down unwanted proteins in the body, helping combat allergies and lower inflammation. It affects mucosal viscosity to support respiratory and immune health. Animal studies show it may reduce cholesterol and fatty deposits, remove fibroids, and break down amyloid plaque. Serrapeptase may also enhance wound healing and provide pain relief.

MD Logic Chairman Wesley Ramjeet added, "I expect we will announce the pre-sale of Serrapeptase 125 this week. I am amazed by our team's efforts to deliver this great product in record time. A special thanks to Jyoti Hardat, VP of Marketing, and André Cecílio, Creative Designer, for working tirelessly with Melanie to bring this to life."

About AvalonX
AvalonX was created by Melanie Avalon in collaboration with MD Logic. Melanie Avalon is the author of What What When What When Wine: Lose Weight and Feel Great with Paleo-Style Meals, Intermittent Fasting, and Wine, and host of The Melanie Avalon Biohacking Podcast and The Intermittent Fasting Podcast with co-host Gin Stephens. Melanie has been highlighted in Forbes and Entrepreneur, and her shows have net 15+ million downloads to date. The mission of AvalonX is purity, potency, transparency, and trust. AvalonX aims to design and create toxic filler-free, plastic-free, gluten-free, allergen-free, mold-free, pure, sustainable, effective, properly formulated supplements to support one's utmost state of longevity and vitality. Serrapeptase 125 is the first of the AvalonX line powered by MD Logics, a USA GMP formulation and manufacturing team. Learn more at http://www.AvalonX.us.

About MD Logic Health
MD Logic Health was founded in 2005 by Dr. Steinfeld, who recognized the importance of providing access to professional grade, pure, high-quality nutrients as part of his patients' overall health care. MD Logic remains dedicated to providing integrated healthcare professionals and patients with the highest grade nutraceuticals. The products are manufactured under USA Good Manufacturing Standards, using sustainable resources and rigorously tested ingredients. MD Logic supports access to nutraceuticals, education, and awareness for today's integrated health care provider and patient. Learn more at http://www.mdlogichealth.com.

MD LOGIC HEALTH CONTACT:
Jyoti Hardat
[email protected]
Phone (877) 629-8711 x700

AVALONX CONTACT:
Melanie Avalon
[email protected]

Media Contact

Jyoti Hardat, MD Logic Wellness, +1 (877) 629-8711 Ext: 700, [email protected]

Twitter, Facebook

SOURCE MD Logic Health

Related Links

https://www.mdlogichealth.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.